TN Toxicology p.1-3 Flashcards
Name 4 principles to consider with all ingestions (4)
- Resuscitation (ABCD3EFG)
- Screening (toxidrome? clinical clues?)
- Decrease absorption of drug
- Increase elimination of drug
Name universal antidotes (4)
DONT
- Dextrose
- Oxygen
- Naloxone
- Thiamine (must give BEFORE dextrose)
Describe use and doses: Dextrose (glucose) (4)
- give to any patient presenting with altered LOC
- measure blood glucose prior to glucose administration if possible
- adults : 0.5-1.0 g/kg (1-2mL/kg) IV of D50W
- children: 0.25 g/kg (2-4mL/kg) IV of D25W
Describe use of oxygen (3)
- do not deprive a hypoxic patient of oxygen no matter what the antecedent medical history (i.e.even COPD with CO2 retention)
- if depression of hypoxic drive, intubate and ventilate
- exception: paraquatordiquat (herbicides) inhalation or ingestion (oxygen radicals increase morbidity)
Describe: Naloxone (4)
- central μ-receptor competitive antagonist
- shorter t1/2 than naltrexone
- antidote for opioids : administration is both diagnostic and therapeutic (1 min onset of action)
- used for the undifferentiated comatose patient
Describe loading dose for adults: Naloxone (2)
- response to naloxone can be drastic, so stepwise delivery of initial 2 mg bolus is recommended
- draw up 2 mg to deliver IV/IM/SL/SC or via ETT (ETT dose = 2-2.5x IV dose)
- 1st dose 0.4 mg (for a chronic opioid user, the initial dose may be much smaller)
- if no response, deliver second dose 0.6 mg
- if still no response, deliver remaining 1 mg
Describe loading dose for child: Naloxone (2)
- 0.01 mg/kg initial bolus IV/IO/ETT (max 2mg per dose)
- children over 20 kg can receive naloxone 2 mg IV
Describe loading maintenance dose: Naloxone (2)
- may be required because half-life of naloxone (30-80 min) is much shorter than many opioids
- hourly infusion rate at 2/3 of initial dose that allowed patient to be roused
Administration of naloxone can cause what in chronic users?
opioid withdrawal
Administration of naloxone can cause opioid withdrawal in chronic users. Name minor withdrawal sx (7)
- lacrimation
- rhinorrhea
- diaphoresis
- yawning
- piloerection
- HTN
- tachycardia
Administration of naloxone can cause opioid withdrawal in chronic users. Name severe withdrawal sx (5)
- hot and cold flashes
- arthralgias
- myalgias
- N/V
- abdominal cramps
Describe thiamine (Vitamine B1) (4)
- 100 mg IV/IM with IV/PO glucose to all patients
- given to prevent/treat Wernicke’s encephalopathy
- a necessary cofactor for glucose metabolism (may worsen Wernicke’s encephalopathy if glucose given before thiamine), but do not delay glucose if thiamine unavailable
- must assume all undifferentiated comatose patients are at risk
Name essential tests for toxicology (9)
- CBC
- electrolytes
- BUN/Cr
- glucose
- INR/PTT
- osmolality
- ABGs
- O2 sat
- ASA, acetaminophen, EtOH levels
Name potentially useful tests for toxicology (10)
- drug levels – this is NOT a serum drug screen
- Ca2+
- Mg2+
- PO43–
- protein
- albumin
- lactate
- ketones
- liver enzymes
- CK
True or false
Negative toxicology screen does not rule out a toxic ingestion
True
signifies only that the specific drugs tested were not detectable in the specimen